Related references
Note: Only part of the references are listed.CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1
Lei Zhang et al.
CELL DEATH & DISEASE (2020)
mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer
Ji Young Chang et al.
YONSEI MEDICAL JOURNAL (2020)
A novel tumor-based epithelial-to-mesenchymal transition score that associates with prognosis and metastasis in patients with Stage II/III colorectal cancer
A. K. Roseweir et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and β-catenin
Kyu Sang Lee et al.
BMC CANCER (2016)
Nuclear expression and/or reduced membranous expression of β-catenin correlate with poor prognosis in colorectal carcinoma A meta-analysis
Shizhen Zhang et al.
MEDICINE (2016)
The prognostic value of CSCs biomarker CD133 in NSCLC: a meta-analysis
Engeng Chen et al.
ONCOTARGET (2016)
Prognostic Significance of Secreted Frizzled-Related Protein 2 Expression in Cytogenetically Normal Primary Acute Myeloid Leukemia
Rabab M. Aly et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2015)
Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma
Qiong Wu et al.
DIAGNOSTIC PATHOLOGY (2015)
Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review
Hui Cao et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
B-cell lymphoma 2 and -catenin expression in colorectal cancer and their prognostic role following surgery
Manuela Balzi et al.
MOLECULAR MEDICINE REPORTS (2015)
Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer
Myung Ah Lee et al.
BMC CANCER (2014)
Elf3 drives β-catenin transactivation and associates with poor prognosis in colorectal cancer
J-L Wang et al.
CELL DEATH & DISEASE (2014)
Differential β-catenin expression levels are associated with morphological features and prognosis of colorectal cancer
Zhao-Hua Gao et al.
ONCOLOGY LETTERS (2014)
Prognostic significance of β-catenin, E-cadherin, and SOX9 in colorectal cancer: results from a large populationp-representative series
Jane Bruun et al.
FRONTIERS IN ONCOLOGY (2014)
Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients
Sang-Jeon Lee et al.
DIAGNOSTIC PATHOLOGY (2013)
Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer
Sakarias Wangefjord et al.
DIAGNOSTIC PATHOLOGY (2013)
SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer
Wonkyung Jung et al.
KOREAN JOURNAL OF PATHOLOGY (2013)
microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis
N. Zhang et al.
ONCOGENE (2013)
Downregulated E-Cadherin Expression Indicates Worse Prognosis in Asian Patients with Colorectal Cancer: Evidence from Meta-Analysis
Xin He et al.
PLOS ONE (2013)
Investigation of β-catenin and E-cadherin Expression in Dukes B2 Stage Colorectal Cancer with Tissue Microarray Method. Is It a Marker of Metastatic Potential in Rectal Cancer?
Laszlo Toth et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Expression of Cyclin D1 Is Associated with β-Catenin Expression and Correlates with Good Prognosis in Colorectal Adenocarcinoma
Kyu Yun Jang et al.
TRANSLATIONAL ONCOLOGY (2012)
Cluster Analysis of Claudin-1 and-4, E-Cadherin, and β-Catenin Expression in Colorectal Cancers
Takashi Matsuoka et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Prognostic Significance of Wnt-1, β-catenin and E-cadherin Expression in Advanced Colorectal Carcinoma
Aleksandra Stanczak et al.
PATHOLOGY & ONCOLOGY RESEARCH (2011)
Prognostic role of β-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer
Massimo Pancione et al.
HUMAN PATHOLOGY (2010)
L1, β-Catenin, and E-Cadherin Expression in Patients With Colorectal Cancer: Correlation With Clinicopathologic Features and Its Prognostic Significance
Qing-Xia Fang et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
The Intratumoral Distribution of Nuclear β-Catenin Is a Prognostic Marker in Colon Cancer
David Horst et al.
CANCER (2009)
Nuclear β-catenin expression as a prognostic factor in advanced colorectal carcinoma
Adam Elzagheid et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination
Dan Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer
Yoon-Jung Boo et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
MUC1 and nuclear β-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis
SE Baldus et al.
CLINICAL CANCER RESEARCH (2004)
Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas
J Bondi et al.
APMIS (2004)
A survival-stratification model of human colorectal carcinomas with β-catenin and p27kip1
PY Cheah et al.
CANCER (2002)
Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer
AV Ougolkov et al.
GASTROENTEROLOGY (2002)
Share Paper
